Kendle to light up Mindspace in MayBusiness StandardKeeping an eye on expanding into a tier-I data center by next year, Kendle, the fifth largest clinical research organisation (CRO) in the world, ...

Siro could be a booster for BioconISI - Emerging Markets (subscription)Biocon will have much to gain from a possible alliance with clinical research organisation Siro Clinpharm. There is a buzz in the markets that the ...and more »

OrbiMed Raises $550 Mn FundVC CircleIn December it made its debut investment in India by picking up a stake in Bangalore-based clinical research organisation Ecron Acunova. ...

OrbiMed launches $550m biopharma and medical device VC fundAltAssetsThe firm recently made its first investment in India, financing a series B round for clinical research organisation Ecron Acunova, through its Caduceus Asia ...and more »

Fidelity PE To Invest In Intas BiopharmaceuticalsVC CircleSiro Clinpharm , a Mumbai-based clinical research organisation in the biotech space, raised funding from 3i Group and Kotak Private Equity. ...

Indian markets open weakEquitymaster.comAs per a leading business daily, Biocon, through its clinical services arm Clinigene is exploring a tie up with a clinical research organisation SIRO ...

India Inc in News - January 27Myiris.comBiotechnology major Biocon`s clinical services arm Clingene is actively exploring an alliance with Mumbai-based clinical research organisation SIRO ...and more »

Biocon's Clingene, SIRO Clinpharm in alliance talksEconomic TimesBANGALORE: Biotechnology major Biocon's clinical services arm Clingene is actively exploring an alliance with Mumbai-based clinical research organisation ...and more »

OSI to expand operations to US, partnership deal soonpharmabiz.comThe Ahmedabad-based Oncology Services India (OSI), a clinical research organisation (CRO) focusing on clinical development of oncology and biotech products, ...

Sudhir Chowdhary, BV MahalakshmiFinancial Express... of Association of Clinical Research Organisation (ACRO). “In the wake of the US drug regulator hardening its stance, sales of 'Made in India' medical ...